Last reviewed · How we verify

NCT04471285

Symphysiolysis: Acupuncture Therapeutic Benefits: a Randomized Placebo Controlled Study.

Completed NA Last updated 4 May 2022
What this trial tests

NA trial testing acupuncture in Single Embryo Pregnancy in 80 participants. Completed in 30 January 2021.

Timeline
1 July 2018
Primary endpoint
30 January 2021
30 January 2021

Quick facts

Lead sponsorShaare Zedek Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 July 2018
Primary completion30 January 2021
Estimated completion30 January 2021
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Shaare Zedek Medical Center

Who can join

18 and older, female only, with Single Embryo Pregnancy or Gestational Weeks 24-42. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

a randomized, observer blind and placebo-controlled cross-over study in which true acupuncture (Verum)(V) was compared to "placebo" acupuncture (P). the investigators evaluate the effect of the acupuncture on the pain and the ability of the pregnant patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

Other Shaare Zedek Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04471285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing